MedTech News
.................... by Andrew Celentano
Medtronic wins FDA clearance for Nellcor pulse oximetry system with intelligent processor
Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent processor.
Medtronic earns CE mark for Stealth AXiS robot platform in ENT surgery
Medtronic (NYSE:MDT) today announced the receipt of CE mark approval for its Stealth AXiS surgical system for ENT procedures.
Engineered stem cells reverse new-onset type 1 diabetes in mice
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease. The work is published in the journal Molecular Therapy.
AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery
The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.
First AI-designed ‘universal vaccine’ tested in humans: UK researchers
The new vaccine aims to produce an immune response that will protect against many pathogens—including some circulating among wild animals that might jump into humans in the future.
Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows
A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has found that a combination prostate cancer treatment could prevent the disease from progressing into a harder-to-treat form of cancer in select patients.
New hantavirus sequencing tool maps whole genomes from hard-to-test samples
A new method for whole-genome sequencing of hantaviruses improves on today’s strategies for identifying outbreaks.
GE HealthCare Receives FDA 510(k) Clearance for MIM Contour ProtégéAI+ 2.0 to Advance AI-Enabled Radiation Therapy Planning
GE HealthCare has received FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, an AI-enabled auto-contouring software designed to assist radiation oncology care teams with treatment planning.